Jennifer A. Karlow

Jennifer A. Karlow

Auto-generated profile, based on publicly available information

Jennifer A. Karlow

Department of Pathology, Dana-Farber Cancer Institute, Boston, MA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2023 in Cancer Research
Verified
Journal Article
Closed access
TKTomas Kanholm
Tomas Kanholm
URUzma Rentia
Uzma Rentia
MHMelissa Hadley
Melissa Hadley
JKJennifer A. Karlow
Jennifer A. Karlow
OCOlivia L. Cox
Olivia L. Cox
KCKatherine B. Chiappinelli
Katherine B. Chiappinelli
Transposable elements (TE) are typically silenced by DNA methylation and repressive histone modifications in differentiated healthy human tissues. However, TE expression increases in a wide range of cancers and is correlated with global hypomethylation of cancer genomes. We assessed expression and DNA methylation of TEs in fibroblast cells that were serially transduced with hTERT, SV40, and HRASR24C to immortalize and then transform them, modeling the different steps of the tumorigenesis process. RNA sequencing and whole-genome bisulfite sequencing were performed at each stage of transformation. TE expression significantly increased as cells progressed through transformation, with the largest increase in expression after the final stage of transformation, consistent with data from human tumors. The upregulated TEs were dominated by endogenous retroviruses [long terminal repeats (LTR)]. Most differentially methylated regions (DMR) in all stages were hypomethylated, with the greatest hypomethylation in the final stage of transformation. A majority of the DMRs overlapped TEs from the RepeatMasker database, indicating that TEs are preferentially demethylated. Many hypomethylated TEs displayed a concordant increase in expression. Demethylation began during immortalization and continued into transformation, while upregulation of TE transcription occurred in transformation. Numerous LTR elements upregulated in the model were also identified in The Cancer Genome Atlas datasets of breast, colon, and prostate cancer. Overall, these findings indicate that TEs, specifically endogenous retroviruses, are demethylated and transcribed during transformation. Significance: Analysis of epigenetic and transcriptional changes in a transformation model reveals that transposable element expression and methylation are dysregulated during oncogenic transformation.

15 June 2022 in Cancer Research
Verified
Journal Article
Closed access
PDF file
JKJennifer A. Karlow
Jennifer A. Karlow
SDSiddhartha Devarakonda
Siddhartha Devarakonda
XXXiaoyun Xing
Xiaoyun Xing
HJHyo Sik Jang
Hyo Sik Jang
RGRamaswamy Govindan
Ramaswamy Govindan
TWTing Wang
Ting Wang
Non–small cell lung cancer (NSCLC) is one of the most commonly diagnosed and deadliest cancers worldwide, with roughly half of all patients initially presenting with both primary and metastatic disease. While the major events in the metastatic cascade have been identified, a mechanistic understanding of how NSCLC routinely and successfully colonizes the brain is largely unknown. Recent studies have begun demonstrating the role of epigenetic misregulation during tumorigenesis and metastasis, including widespread changes in DNA methylation and histone modifications. To better understand the role of altered DNA methylation in NSCLC metastasis to the brain, we measured DNA methylation during disease progression for 12 patients, globally profiling the methylation status of normal lung, primary lung tumor, and brain metastasis samples. The variation in methylation was similar during metastatic spread and primary tumorigenesis but less coordinated across genomic features during metastasis. The greatest recurrent changes during metastatic progression were methylation gains in DNA methylation valleys (DMV) harboring the constitutive heterochromatin mark H3K9me3 as well as bivalent marks H3K27me3 and H3K4me1. In a lymph node–derived cancer cell line, EZH2 binding within DMVs was lost, accompanied by an increase in DNA methylation, exemplifying epigenetic switching. The vast majority of the differentially methylated region–associated DMVs harbored developmental genes, suggesting that altered epigenetic regulation of developmentally important genes may confer a selective advantage during metastatic progression. The characterization of epigenetic changes during NSCLC brain metastasis identified recurrent methylation patterns that may be prognostic biomarkers and contributors to disease progression. Significance: Altered DNA methylation in lung cancer brain metastases corresponds with loss of EZH2 occupancy at developmental genes, which could promote stem-like phenotypes permissive of dissemination and survival in different microenvironments.

1 July 2007 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
AJAmie T. Joyce
Amie T. Joyce
YZYang Zhao
Yang Zhao
LBLee Bowman
Lee Bowman
JFJennifer A. Flynn
Jennifer A. Flynn
CCChureen T. Carter
Chureen T. Carter
DODaniel A. Ollendorf
Daniel A. Ollendorf

17 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
CMCarlos Mendez-Dorantes
Carlos Mendez-Dorantes
XZXi Zeng
Xi Zeng
JKJennifer A Karlow
Jennifer A Karlow
PSPhillip Schofield
Phillip Schofield
STSerafina Turner
Serafina Turner
CZCheng-Zhong Zhang
Cheng-Zhong Zhang
SUMMARY: LINE-1 (L1) retrotransposition is widespread in many cancers, especially those with a high burden of chromosomal rearrangements. However, whether and to what degree L1 activity directly impacts genome integrity is unclear. Here, we apply whole-genome sequencing to experimental models of L1 expression to comprehensively define the spectrum of genomic changes caused by L1. Combining the analyses of experimental models of L1 induction and of cancer genomes, we demonstrate that L1 retrotransposition can directly generate reciprocal translocations, genomic DNA inversions, and foldback rearrangements resulting from illegitimate recombination of double-strand DNA ends generated by L1-encoded ORF2p. We further show that L1-induced rearrangements can produce unstable chromosomes that fuel the acquisition of complex rearrangements, large segmental copy-number alterations, and genetic heterogeneity through breakage-fusion bridge cycles or DNA fragmentation. Together, these findings suggest L1 as a potent mutagenic force capable of driving genome evolution in cancers.

22 September 2023 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
JKJennifer A. Karlow
Jennifer A. Karlow
EPErica C. Pehrsson
Erica C. Pehrsson
XXXiaoyun Xing
Xiaoyun Xing
MWMark Watson
Mark Watson
SDSiddhartha Devarakonda
Siddhartha Devarakonda
TWTing Wang
Ting Wang
Epigenetic alterations are widespread in cancer and can complement genetic alterations to influence cancer progression and treatment outcome. To determine the potential contribution of DNA methylation alterations to tumor phenotype in non-small cell lung cancer (NSCLC) in both smoker and never-smoker patients, we performed genome-wide profiling of DNA methylation in 17 primary NSCLC tumors and 10 matched normal lung samples using the complementary assays, methylated DNA immunoprecipitation sequencing (MeDIP-seq) and methylation sensitive restriction enzyme sequencing (MRE-seq). We reported recurrent methylation changes in the promoters of several genes, many previously implicated in cancer, including FAM83A and SEPT9 (hypomethylation), as well as PCDH7, NKX2-1, and SOX17 (hypermethylation). Although many methylation changes between tumors and their paired normal samples were shared across patients, several were specific to a particular smoking status. For example, never-smokers displayed a greater proportion of hypomethylated differentially methylated regions (hypoDMRs) and a greater number of recurrently hypomethylated promoters, including those of ASPSCR1, TOP2A, DPP9, and USP39, all previously linked to cancer. Changes outside of promoters were also widespread and often recurrent, particularly methylation loss over repetitive elements, highly enriched for ERV1 subfamilies. Recurrent hypoDMRs were enriched for several transcription factor binding motifs, often for genes involved in signaling and cell proliferation. For example, 71% of recurrent promoter hypoDMRs contained a motif for NKX2-1. Finally, the majority of DMRs were located within an active chromatin state in tissues profiled using the Roadmap Epigenomics data, suggesting that methylation changes may contribute to altered regulatory programs through the adaptation of cell type-specific expression programs.

9 September 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JFJennifer A. Flynn
Jennifer A. Flynn
DPDeepak Purushotham
Deepak Purushotham
MCMayank N. K. Choudhary
Mayank N. K. Choudhary
XZXiaoyu Zhuo
Xiaoyu Zhuo
CFChangxu Fan
Changxu Fan
TWTing Wang
Ting Wang